DJ
Therapeutic Areas
Precision BioSciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PBGENE-HBV | Chronic Hepatitis B Virus (HBV) Infection | Phase 1/2 |
| PBGENE-DMD | Duchenne Muscular Dystrophy (DMD) | Phase 1/2 |
| Azer-cel (PBCAR0191) | Multiple Sclerosis | Phase 1/2 |
Leadership Team at Precision BioSciences
MA
Michael Amoroso
Chief Executive Officer
JA
John A. Kelly
Chief Financial Officer
AG
Alexandra Glucksmann, Ph.D.
Chief Operating Officer
BD
Brendan D. Miller
General Counsel
BJ
B. Jefferson (Jeff) Smith, Ph.D.
SVP, Corporate Development & Strategy
MC
Matthew C. Kane
President & Chief Business Officer